Page last updated: 2024-08-25

chitosan and Eye Disorders

chitosan has been researched along with Eye Disorders in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (25.00)29.6817
2010's8 (50.00)24.3611
2020's4 (25.00)2.80

Authors

AuthorsStudies
Liu, J; Peng, Q; Tang, X; Yan, R1
Arafa, MG; El-Dahan, MS; Girgis, GNS1
Jain, A; Jain, SK; Panda, PK; Saraf, S; Tiwari, A; Verma, A1
Huang, S; Li, T; Xing, Y; Zhang, K; Zhu, L1
Ban, J; Chen, Y; Deng, H; Du, Y; Hou, D; Huang, X; Lu, Z; Mo, Z; Shen, L; Wen, Y; Xie, Q; Zhang, S; Zhang, Y1
Detsi, A; Pontillo, ARN1
Chen, Q; Fan, L; Li, W; Qin, Z; Zhao, L; Zhao, M; Zhou, J1
Chen, H; Li, X; Liang, R; Luo, Z; Shi, S; Yu, J; Zhang, Z1
Agrahari, V; Mitra, AK; Pal, D; Sheng, Y; Trinh, HM; Yang, X1
Kanwar, JR; Kanwar, RK; Ram, J; Sunkireddy, P1
Alonso, MJ; de la Fuente, M; Paolicelli, P; Sánchez, A; Seijo, B1
Alonso, MJ; de la Fuente, M; Paolicelli, P; Raviña, M; Sanchez, A; Seijo, B1
Paliwal, R; Paliwal, SR; Vyas, SP; Wadhwa, S1
Başaran, E; Yazan, Y1
Gupta, H; Jain, S; Mathur, R; Mishra, AK; Mishra, P; Velpandian, T1
Alonso, MJ; de la Fuente, M; Seijo, B1

Reviews

6 review(s) available for chitosan and Eye Disorders

ArticleYear
Carbohydrate polymer-based bioadhesive formulations and their potentials for the treatment of ocular diseases: A review.
    International journal of biological macromolecules, 2023, Jul-01, Volume: 242, Issue:Pt 3

    Topics: Chitosan; Drug Delivery Systems; Eye; Eye Diseases; Humans; Hyaluronic Acid; Polymers

2023
Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
    Nanomedicine (London, England), 2019, Volume: 14, Issue:14

    Topics: Administration, Ophthalmic; Animals; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Eye; Eye Diseases; Humans; Nanoparticles; Nanotechnology; Pharmaceutical Preparations; Polylactic Acid-Polyglycolic Acid Copolymer

2019
Chitosan nanoparticles for drug delivery to the eye.
    Expert opinion on drug delivery, 2009, Volume: 6, Issue:3

    Topics: Administration, Topical; Animals; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Compounding; Eye; Eye Diseases; Gene Transfer Techniques; Humans; Nanoparticles; Ophthalmic Solutions

2009
Chitosan-based nanostructures: a delivery platform for ocular therapeutics.
    Advanced drug delivery reviews, 2010, Jan-31, Volume: 62, Issue:1

    Topics: Administration, Topical; Animals; Chitosan; Drug Delivery Systems; Epithelium, Corneal; Eye Diseases; Gene Transfer Techniques; Humans; Nanostructures

2010
Chitosan and its role in ocular therapeutics.
    Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:14

    Topics: Chitosan; Drug Delivery Systems; Eye Diseases; Gels; Humans; Liposomes; Nanoparticles; Polyelectrolytes; Polymers; Solubility

2009
Ocular application of chitosan.
    Expert opinion on drug delivery, 2012, Volume: 9, Issue:6

    Topics: Animals; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Eye Diseases; Gels; Humans; Nanoparticles; Ophthalmic Solutions; Pharmaceutical Preparations; Polymers

2012

Other Studies

10 other study(ies) available for chitosan and Eye Disorders

ArticleYear
Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Atorvastatin; Biocompatible Materials; Biological Availability; Chitosan; Drug Carriers; Drug Delivery Systems; Eye Diseases; Gels; Inflammation; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits

2020
Promising Antifungal Potential of Engineered Non-ionic Surfactant-Based Vesicles: In Vitro and In Vivo Studies.
    AAPS PharmSciTech, 2021, Jan-03, Volume: 22, Issue:1

    Topics: Animals; Antifungal Agents; Cations; Chitosan; Drug Carriers; Drug Liberation; Eye Diseases; Hexoses; In Vitro Techniques; Liposomes; Mycoses; Particle Size; Rabbits; Surface-Active Agents

2021
Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation.
    Artificial cells, nanomedicine, and biotechnology, 2021, Volume: 49, Issue:1

    Topics: Animals; Chitosan; Drug Carriers; Eye Diseases; Inflammation; Nanostructures; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Triamcinolone Acetonide

2021
Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone.
    Nanomedicine (London, England), 2018, Volume: 13, Issue:11

    Topics: Animals; Biological Availability; Chitosan; Cornea; Delayed-Action Preparations; Dexamethasone; Drug Carriers; Drug Liberation; Eye Diseases; Humans; Lipids; Nanostructures; Ophthalmic Solutions; Rabbits

2018
Inhibitory effect of chitooligosaccharides on retinol metabolism and bioavailability in mice.
    Journal of food biochemistry, 2019, Volume: 43, Issue:5

    Topics: Acyltransferases; Animals; Chitin; Chitosan; Eye Diseases; Humans; Mice; Occupational Exposure; Oligosaccharides; Retinoic Acid 4-Hydroxylase; Retinol-Binding Proteins, Cellular; Retinol-Binding Proteins, Plasma; Risk; Vitamin A

2019
Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac.
    Scientific reports, 2015, Jun-12, Volume: 5

    Topics: Animals; Chitosan; Diclofenac; Drug Carriers; Eye Diseases; Humans; Male; Mice; Ophthalmic Solutions; Polyesters; Polyethylene Glycols; Rabbits

2015
Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
    AAPS PharmSciTech, 2016, Volume: 17, Issue:2

    Topics: Administration, Ophthalmic; Administration, Topical; Biological Availability; Cell Line; Chemistry, Pharmaceutical; Chitosan; Corneal Keratocytes; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Emulsions; Eye Diseases; Gels; Humans; Hydrocortisone; Nanoparticles; Ocular Absorption; Particle Size; Poloxamer; Polyvinyl Alcohol

2016
Ultra-small algal chitosan ocular nanoparticles with iron-binding milk protein prevents the toxic effects of carbendazim pesticide.
    Nanomedicine (London, England), 2016, Volume: 11, Issue:5

    Topics: Animals; Apoptosis; Benzimidazoles; Carbamates; Cattle; Chitosan; Drug Delivery Systems; Eye Diseases; Humans; Iron-Binding Proteins; Lactoferrin; Milk Proteins; Nanoparticles; Oxidative Stress; Pesticides; Rats; Tissue Distribution

2016
Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
    Drug delivery, 2007, Volume: 14, Issue:8

    Topics: Animals; Biological Availability; Chick Embryo; Chitosan; Chorioallantoic Membrane; Cornea; Delayed-Action Preparations; Drug Delivery Systems; Drug Packaging; Eye Diseases; Female; Gels; Goats; Hydrogen-Ion Concentration; Instillation, Drug; Male; Parabens; Poloxamer; Rabbits; Radionuclide Imaging; Temperature; Timolol; Toxicity Tests, Acute; Viscosity

2007
Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue.
    Gene therapy, 2008, Volume: 15, Issue:9

    Topics: Animals; Biocompatible Materials; Biological Transport; Cells, Cultured; Chitosan; Conjunctiva; Cornea; DNA; Epithelium, Corneal; Eye Diseases; Genetic Therapy; Humans; Hyaluronic Acid; Male; Microscopy, Confocal; Models, Animal; Nanoparticles; Nanotechnology; Rabbits; Transfection

2008